Protection from gastrointestinal diseases with the use of probiotics.
about
Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells.Probiotics and medical nutrition therapyThe host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1Gut microbiota imbalance and colorectal cancerRole of Probiotics in health improvement, infection control and disease treatment and managementMicrobiota impact on the epigenetic regulation of colorectal cancerGenomic and metabolic studies of the impact of probiotics on a model gut symbiont and hostA meta-analysis of probiotic efficacy for gastrointestinal diseasesEradication of Salmonella Typhimurium infection in a murine model of typhoid fever with the combination of probiotic Lactobacillus fermentum ME-3 and ofloxacinProbiotics for standard triple Helicobacter pylori eradication: a randomized, double-blind, placebo-controlled trial.Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells.Association of beta-glucan endogenous production with increased stress tolerance of intestinal lactobacilliProtein calorie malnutrition, nutritional intervention and personalized cancer care.Clinical nutrition: 7. Functional foods--more than just nutritionSurvival of probiotic lactobacilli in acidic environments is enhanced in the presence of metabolizable sugarsStudy of adhesion and survival of lactobacilli and bifidobacteria on table olives with the aim of formulating a new probiotic food.Effects of probiotic bacteria on gastrointestinal motility in guinea-pig isolated tissueGut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis.Effect of L. plantarum cell-free extract and co-trimoxazole against Salmonella Typhimurium: a possible adjunct therapy.Lactobacillus GG restoration of the gliadin induced epithelial barrier disruption: the role of cellular polyamines.HIV and the gut microbiota, partners in crime: breaking the vicious cycle to unearth new therapeutic targets.Dysbiotic bacteria translocate in progressive SIV infection.Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon.Systems Modeling of Interactions between Mucosal Immunity and the Gut Microbiome during Clostridium difficile InfectionAnti-Inflammatory Effects of Lactobacillus Rahmnosus and Bifidobacterium Breve on Cigarette Smoke Activated Human Macrophages.Functional Starters for Functional Yogurt.Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques.Lactobacillus fermentum ME-3 - an antimicrobial and antioxidative probioticLive Lactobacillus rhamnosus [corrected] is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression.Modulation of vaccine response by concomitant probiotic administration.Enterococcus faecium WB2000 Inhibits Biofilm Formation by Oral Cariogenic Streptococci.Potent antagonistic activity of Egyptian Lactobacillus plantarum against multiresistant and virulent food-associated pathogens.Suppression of tumorigenesis: modulation of inflammatory cytokines by oral administration of microencapsulated probiotic yogurt formulation.Effect of the probiotic Lactobacillus murinus LbP2 on clinical parameters of dogs with distemper-associated diarrheaBeta-glucans improve growth, viability and colonization of probiotic microorganisms.Probiotics and ileitis: could augmentation of TNF/NFκB activity be the answer?Three New Lactobacillus plantarum Strains in the Probiotic Toolbox against Gut Pathogen Salmonella enterica Serotype Typhimurium.Probiotics-mixed messages.Removal of cholera toxin from aqueous solution by probiotic bacteriaImposition of encapsulated non-indigenous probiotics into intestine may disturb human core microbiome.
P2860
Q24545538-EDBE33A1-C669-4323-A6CF-615F7E0E60C6Q24548441-144AD750-CF06-492A-AAC2-69610B183EDDQ25256884-3F7E46DC-5375-4D78-839E-D72B8CCC6A32Q26774708-D9F144AD-E9C7-4ECF-BCDB-AB159094C6D7Q27008261-8A3BD052-493F-484A-9164-E42A63297205Q27028132-148BA913-0AEC-4284-A077-764E11D67D90Q27335019-33C9F67A-7879-47CD-9B98-F97DFFE1DD89Q31057363-8467EC23-CAFF-46A0-88E5-D8B5E40785AFQ33357682-7A763C02-D3F4-4F5A-A9D3-9BB9D1FD9563Q33464907-8B760B8B-EF0F-490C-BE79-BA8447542C59Q33554139-6CE7DD38-4D0B-4561-BC9D-8E372D0EAE35Q33585577-71E453C4-F179-415B-96CC-D07A49126B92Q33618955-03681C99-4C42-42B3-976D-D09402DD1BFFQ33833300-06F0ACDF-E992-42DF-B270-E9B771DB1E76Q33855902-2471BC9E-A071-40D6-A477-3D364F8284B6Q33913263-A367557A-12D6-4336-ACA2-4C2728C708B9Q34013048-77BB05ED-BF42-4AE4-8165-F22112BB148FQ34192292-0B632302-FC5F-44C3-859E-99DF0452F66CQ34668105-39B7C423-F40B-450D-A4F5-BD05EB820798Q35086617-0E9E88E3-B504-450B-B65E-26D3DEF783EEQ35156136-25D148F9-E34A-4B26-A470-839B2017CED9Q35542433-A615E534-45F3-4491-BBEC-FEA718F7401AQ35598397-ECDB43A9-D399-49F0-B879-07B25DDE2A52Q35729663-8A970F07-0C48-4C84-864A-EEEC2F65E664Q35758923-09086D6A-00A6-4028-BE44-23E99EBC985AQ36288269-DA4B4A6A-9C1D-41D8-B894-76C04D01F65EQ36580442-C8FFF4C9-8745-4F22-BD9B-27039AF93477Q37161945-E50324F5-BADE-4988-9929-0DBC5121EAF6Q37521881-2E458D6D-0AEB-426F-AD60-57FC9ED81463Q38030588-323EF6D1-EB99-4D20-82A2-A888EEF23731Q38896444-66C8E5CF-939A-4AB1-B219-646E6E10D926Q40562587-BA8F64D9-04FE-46F7-A89A-363808B5853DQ41218734-7D555E29-7AD2-4929-B893-5FC033888955Q41636049-4B0F4276-597D-411B-8C72-E10A5633361AQ41985243-FEF5779F-DEFC-47C3-9B4F-476C31CB07A7Q42234301-9C7B3E3F-5CE7-46A4-89A4-DFCBA3C45153Q42261998-62F3C5DE-1EE2-4901-B970-80DD19E475DEQ42408228-3673454D-111D-4DAA-9037-E799A7FC7E4CQ42585810-611B2F1F-2CC1-4F48-8D8C-DDB377FEABA3Q42694838-0A1CDE75-C4EE-4E80-9AD4-92232AFF6488
P2860
Protection from gastrointestinal diseases with the use of probiotics.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Protection from gastrointestinal diseases with the use of probiotics.
@ast
Protection from gastrointestinal diseases with the use of probiotics.
@en
Protection from gastrointestinal diseases with the use of probiotics.
@nl
type
label
Protection from gastrointestinal diseases with the use of probiotics.
@ast
Protection from gastrointestinal diseases with the use of probiotics.
@en
Protection from gastrointestinal diseases with the use of probiotics.
@nl
prefLabel
Protection from gastrointestinal diseases with the use of probiotics.
@ast
Protection from gastrointestinal diseases with the use of probiotics.
@en
Protection from gastrointestinal diseases with the use of probiotics.
@nl
P2093
P356
P1476
Protection from gastrointestinal diseases with the use of probiotics.
@en
P2093
Cellier CJ
Marteau PR
Schrezenmeir J
de Vrese M
P304
P356
10.1093/AJCN/73.2.430S
P407
P433
P577
2001-02-01T00:00:00Z